MedPath

PFIZER PRIVATE LIMITED

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

196

HSA:196

Drug Approvals

TALZENNA CAPSULE 0.5MG

Approval Date
May 21, 2025
HSA

TALZENNA CAPSULE 0.1MG

Approval Date
May 21, 2025
HSA

TALZENNA CAPSULE 0.35MG

Approval Date
May 21, 2025
HSA

HYMPAVZI SOLUTION FOR INJECTION IN SINGLE-DOSE PRE-FILLED PEN 150 MG/ML

Approval Date
Feb 27, 2025
HSA

ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML

Approval Date
Dec 31, 2024
HSA

ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML

Approval Date
Dec 31, 2024
HSA

ABRYSVO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Approval Date
Jul 23, 2024
HSA

LITFULO CAPSULE 50MG

Approval Date
Jul 5, 2024
HSA

VELSIPITY FILM-COATED TABLET 2 MG

Approval Date
May 30, 2024
HSA

NGENLA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 60 MG/1.2ml

Approval Date
Dec 14, 2023
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 20
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.